Company Filing History:
Years Active: 2012
Title: The Innovations of Leo C James
Introduction
Leo C James is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of immunology through his innovative work. His research focuses on the prevention of aggregation of immunoglobulin light or heavy chains, which is crucial for various medical applications.
Latest Patents
Leo C James holds a patent for the "Prevention of aggregation of immunoglobulin light or heavy chains." This patent describes an inhibitor that may comprise or consist of a polypeptide with specific amino acid sequences. These sequences correspond to the FR1 region of an immunoglobulin light chain variable domain and the immunoglobulin-binding domains of bacterial superantigen Protein L and streptococcal protein G. The invention aims to inhibit the aggregation of immunoglobulin chains, which can have significant implications in therapeutic settings.
Career Highlights
Leo C James is associated with Glaxo Group Limited, where he has been able to apply his expertise in immunology. His work has contributed to advancements in the understanding and treatment of various diseases related to immunoglobulin aggregation.
Collaborations
Throughout his career, Leo has collaborated with esteemed colleagues such as Rudolf M T De Wildt and Philip Jones. These collaborations have further enriched his research and innovation in the field.
Conclusion
In summary, Leo C James is a distinguished inventor whose work on immunoglobulin aggregation has the potential to impact medical science significantly. His contributions through patents and collaborations highlight his importance in the field of immunology.